Hinge Health, Inc.
$58.66
+6.6%Hinge Health, Inc. develops health care software for joint and muscle health. The company designs its platform to address a musculoskeletal care, acute injury, chronic pain, and post-surgical rehabilitation. It also provides various administrative and operations support services. The company was founded in 2012 and is headquartered in San Francisco, California.
At a Glance
Live SnapshotIntrinsic Alpha Methodology
Thesis Lenses
Signal
Medium confidenceValuation multiple is compressed (P/E -7.0).
Valuation inputs: P/E -7.0, earnings yield N/A, momentum +6.6%.
If multiples stay elevated while momentum fades, downside repricing risk rises.
Driver
High confidenceReturn profile is soft (ROE -1.4%, ROIC -1.4%).
Profitability stack: net margin -89.9%, ROE -1.4%, ROIC -1.4%.
Quality deterioration often appears in margins before it shows up in headline EPS.
Risk
High confidenceRisk profile is balanced but has notable pressure points to monitor.
Risk factors: liabilities/assets +49.2%, momentum +6.6%, net margin -89.9%.
Higher leverage with weak momentum and thin margins can amplify drawdown severity.
Hinge Health, Inc. Market vs Earnings Trajectory
Loading price and EPS data...
Hinge Health, Inc. Fair Value Envelope
Hinge Health, Inc. Profit Bridge
Profitability Analysis
Gross Margin
Exceptional pricing power and cost management. The company retains over half of revenue after direct costs.
Operating Margin
Operating losses indicate the core business is unprofitable. Requires restructuring or revenue growth.
Net Profit Margin
Net losses indicate the company is burning cash. Sustainability depends on path to profitability.
Profitability Insight
Margin squeeze alert: Healthy gross margins but weak operating margins suggest excessive operating expenses. Cost optimization could unlock significant value.
Hinge Health, Inc. Cash Conversion Engine
Cash Flow Quality Analysis
FCF Conversion Rate
Negative free cash flow despite positive earnings raises concerns about cash generation ability or heavy capital requirements.
CapEx Intensity
Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.
FCF Growth Trend
Strong FCF growth demonstrates improving cash generation and business momentum. Positive signal for sustainability.
Working Capital Impact
Minimal working capital impact on FCF. Changes in operating assets and liabilities well-managed.
Hinge Health, Inc. Funding & Solvency Profile
Financial Health Analysis
Current Ratio
Acceptable liquidity, but monitor closely. Current assets just barely cover current liabilities.
Debt-to-Equity Ratio
Elevated leverage. Debt exceeds equity, which amplifies both gains and risks. Monitor debt servicing ability.
Working Capital
Positive working capital, but relatively tight. The company should monitor cash flow carefully.
Asset Composition
Asset-light business model with high liquidity. Majority of assets are easily convertible to cash.
Hinge Health, Inc. Street Expectations Map
Wall Street analysts project that HNGE stock may rise significantly over the coming 12 months. The consensus 1-year price target stands at 65.82, with estimates ranging from a low of 45.00 to a high of 95.00.
The consensus 1-year price target stands at 65.82, with estimates ranging from a low of 45.00 to a high of 95.00.
Analyst Consensus Analysis
Upside Potential
Moderate upside. Analysts expect positive returns but with limited margin of safety. Consider entry timing.
Analyst Agreement
High uncertainty. Very wide target spread indicates significant disagreement among analysts—major valuation uncertainty or transformation underway.
Risk-Reward Profile
Favorable risk-reward. Potential upside significantly exceeds downside risk, offering asymmetric return profile attractive for risk-tolerant investors.
Analyst Conviction
High uncertainty: Wide dispersion indicates analysts struggle to agree on valuation—proceed with caution and independent analysis.
Market Sentiment Insight
Extreme uncertainty: Massive dispersion in price targets reflects fundamental disagreement on business trajectory. This could signal transformation, disruption, or complex valuation—requires deep sector expertise and contrarian mindset.
Hinge Health, Inc. Insider Positioning
During the last 12 months, insiders have sold $47.67M worth of HNGE shares, with no buying activity reported.
3 Months
0
0.00
376.0K
18.69M
-18.7M
-$18.69M
3-6 Months
0
0.00
483.6K
21.73M
-21.7M
-$21.73M
6-9 Months
0
0.00
152.8K
7.25M
-7.3M
-$7.25M
9-12 Months
0
0.00
0
0.00
+0
+$0
Top Buyers
No buying activity
Top Sellers
Perez Daniel Antonio
Director, 10 Percent Owner, Officer: Ceo & Co-Founder
$28.45M
Mecklenburg Gabriel M.I.
Director, Other: Exec. Chairman & Co-Founder
$9.86M
Insight Holdings Group, Llc
10 Percent Owner
$6.26M
Budge James
Officer: Chief Financial Officer
$1.81M
Pursley James
Officer: President
$1.03M
Insider Activity Analysis
Net Insider Sentiment
Strong bearish signal with $47.67M net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.
Buy/Sell Ratio
Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.
Recent Trend (3 Months)
Heavy recent selling activity. Recent insider sales notably exceed purchases—may warrant investigation into company developments.
Insider Participation
5 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.
Insider Activity Insight
Multiple red flags: Heavy selling, numerous sellers, and continued recent selling create a concerning pattern. Investigate fundamental drivers and consider whether company guidance or industry conditions have deteriorated.
No Dividend Yield Data
HNGE has not reported any dividend yield values in the available annual periods.
hnge Dividend History
Learning Layer
Related Guides
Build conviction on HNGE by pairing this stock hub with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.